Ntla stock price target

Intellia Therapeutics, Inc. (NTLA) Stock Forum ... Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Intellia Therapeutics - NTLA - Stock Price & News | The ... Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Intellia Therapeutics, Inc. Common Stock (NTLA) Real-Time ... NTLA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

Their average twelve-month price target is $26.42, suggesting that the stock has a possible upside of 120.32%. The high price target for NTLA is $57.50 and the

NTLA Stock Price & Charts | Intellia Therapeutics In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Analysts Have Mixed Ratings On Intellia Therapeutics Inc ... The stock was given Neutral rating by ROTH Capital in its report released on June 10, 2019, the day when the price target on the stock was placed at 16. Wedbush was of a view that NTLA is Outperform in its latest report on May 03, 2019. Evercore ISI thinks that NTLA is …

Intellia Therapeutics, Inc. (NTLA) Stock Price, Quote ...

Intellia Therapeutics (NASDAQ:NTLA) Stock Rating ...

In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

Intellia Therapeutics (NASDAQ:NTLA) ‘s stock had its “buy” rating reiterated by stock analysts at Chardan Capital in a research note issued on Tuesday, TipRanks reports. They presently have a $57.50 price target on the stock. Chardan Capital’s target price would suggest a potential upside of 370.16% from the company’s current price. Intellia Therapeutics, Inc. (NTLA) stock price, quote ... Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of -5.56% and 14.56%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock? Intellia Therapeutics, Inc. (NTLA), a leading genome editing company focused on … Intellia Therapeutics (NASDAQ:NTLA) Stock Rating ... 4 days ago · Intellia Therapeutics (NASDAQ:NTLA) ‘s stock had its “buy” rating reissued by analysts at BTIG Research in a report released on Thursday, TipRanks reports. They currently have a $22.00 price objective on the stock. BTIG Research’s price objective would suggest a potential upside of 83.49% from the company’s current price.

Analyst Actions: Oppenheimer Upgrades Intellia Therapeutics to Outperform From Perform 8:42AM ET 2/28/2020 MT Newswires. Intellia Therapeutics' (NTLA) average rating among analysts is a buy, with an average price target of $27.

4 days ago · Intellia Therapeutics (NASDAQ:NTLA)‘s stock had its “buy” rating reaffirmed by BTIG Research in a report issued on Thursday, TipRanks reports. They presently have a …